pumped after reading that and the manufacturing bit at the end. Buying under 10c is a must l reckon, we so going to fly this year...
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren completes Phase 2 trial in pediatric Rett syndrome
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.71%
!
$14.21

Ann: Neuren completes Phase 2 trial in pediatric Rett syndrome, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.21 |
Change
0.100(0.71%) |
Mkt cap ! $1.759B |
Open | High | Low | Value | Volume |
$14.11 | $14.29 | $13.85 | $1.995M | 141.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 39 | $14.21 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.22 | 75 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 266 | 14.200 |
10 | 944 | 14.190 |
9 | 1423 | 14.180 |
7 | 1278 | 14.170 |
5 | 1181 | 14.160 |
Price($) | Vol. | No. |
---|---|---|
14.220 | 158 | 5 |
14.230 | 531 | 4 |
14.240 | 2242 | 7 |
14.250 | 1508 | 6 |
14.260 | 1140 | 4 |
Last trade - 13.23pm 01/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online